Larvol Delta - Safety-Tolerability-and-AntiTumor-Activity-of-AFM24-in-Combination-With-SNK01-in-Subjects-With-AdvancedMetastatic-EGFRExpressing-Cancers

SNK01 - NKMAX

AFM24 - Affimed

http://clinicaltrials.gov/ct2/show/NCT05099549

Mar 1, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next